Michael Rogers
2016 - Acorda Therapeutics
In 2016, Michael Rogers earned a total compensation of $1.8M as Chief Financial Officer former at Acorda Therapeutics, a 23% increase compared to previous year.
Compensation breakdown
| Bonus | $25,000 |
|---|---|
| Non-Equity Incentive Plan | $157,358 |
| Option Awards | $632,304 |
| Salary | $412,773 |
| Stock Awards | $408,027 |
| Other | $132,404 |
| Total | $1,767,866 |
Rogers received $632.3K in option awards, accounting for 36% of the total pay in 2016.
Rogers also received $25K in bonus, $157.4K in non-equity incentive plan, $412.8K in salary, $408K in stock awards and $132.4K in other compensation.
Rankings
In 2016, Michael Rogers' compensation ranked 5,462nd out of 14,075 executives tracked by ExecPay. In other words, Rogers earned more than 61.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,462 out of 14,075 | 61st |
Division Manufacturing | 1,957 out of 5,489 | 64th |
Major group Chemicals And Allied Products | 618 out of 1,895 | 67th |
Industry group Drugs | 461 out of 1,538 | 70th |
Industry Biological Products, Except Diagnostic Substances | 81 out of 279 | 71st |
Source: SEC filing on April 21, 2017.
Rogers' colleagues
We found five more compensation records of executives who worked with Michael Rogers at Acorda Therapeutics in 2016.
2016
Burkhard Blank
Acorda Therapeutics
Chief Medical Officer
2016
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2016
Jane Wasman
Acorda Therapeutics
General Counsel
2016
Andrew Hindman
Acorda Therapeutics
Chief Business Development Officer
2016
David Lawrence
Acorda Therapeutics